Published Papers & Misc - TAMURA Kaoru

21. Shirahata Mitsuaki, Adachi Junichi, Kobayashi Keiichi, Yamasaki Fumiyuki, Tamura Kaoru, Suzuki Tomonari, Mishima Kazuhiko, Nagane Motoo, Ichimura Koichi, Nishikawa Ryo. Stratified monotherapy approach according to MGMT methylation status in elderly patients with glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. 2019.05; 37 (15):

22. Arita Hideyuki, Ohio Makoto, Nakamura Taishi, Tamura Kaoru, Miyake Yohei, Saito Kuniaki, Tanaka Shota, Higuchi Fumi, Kanemura Yonehiro, Ichimura Koichi. Prognostic impact of TERT promoter mutation suggests its utility as a surrogate marker for 1p/19q codeletion in IDH mutated gliomas BRAIN PATHOLOGY. 2019.02; 29 193.

23. Tomoyuki Nakano, Kaoru Tamura, Yoji Tanaka, Motoki Inaji, Shihori Hayashi, Daisuke Kobayashi, Tadashi Nariai, Jun Toyohara, Kenji Ishii, Taketoshi Maehara. C-Methionine Positron Emission Tomography for Monitoring of Treatment Response and Recurrence in a Glioblastoma Patient on Bevacizumab Therapy: A Case Report. Case Rep Oncol. 2018.07; 11 (2): 442-449. ( PubMed, DOI )

24. Deepak Bhere, Kaoru Tamura, Hiroaki Wakimoto, Sung Hugh Choi, Benjamin Purow, Jeremy Debatisse, Khalid Shah. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis. Neuro-oncology. 2018.01; 20 (2): 215-224. ( PubMed, DOI )

25. Sung Hugh Choi, Daniel W Stuckey, Sara Pignatta, Clemens Reinshagen, Jasneet Kaur Khalsa, Nicolaas Roozendaal, Jordi Martinez-Quintanilla, Kaoru Tamura, Erhan Keles, Khalid Shah. Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas. Clin. Cancer Res.. 2017.11; 23 (22): 7047-7058. ( PubMed, DOI )

26. Xiaoshu Dong, Kaoru Tamura, Daisuke Kobayashi, Noboru Ando, Kazutaka Sumita, Taketoshi Maehara. LAPTM4B-35 is a novel prognostic factor for glioblastoma. J. Neurooncol.. 2017.04; 132 (2): 295-303. ( PubMed, DOI )

27. Shintaro Fukushima, Satoshi Yamashita, Hisato Kobayashi, Hirokazu Takami, Kohei Fukuoka, Taishi Nakamura, Kai Yamasaki, Yuko Matsushita, Hiromi Nakamura, Yasushi Totoki, Mamoru Kato, Tomonari Suzuki, Kazuhiko Mishima, Takaaki Yanagisawa, Akitake Mukasa, Nobuhito Saito, Masayuki Kanamori, Toshihiro Kumabe, Teiji Tominaga, Motoo Nagane, Toshihiko Iuchi, Koji Yoshimoto, Masahiro Mizoguchi, Kaoru Tamura, Keiichi Sakai, Kazuhiko Sugiyama, Mitsutoshi Nakada, Kiyotaka Yokogami, Hideo Takeshima, Yonehiro Kanemura, Masahide Matsuda, Akira Matsumura, Kazuhiko Kurozumi, Keisuke Ueki, Masahiro Nonaka, Akio Asai, Nobutaka Kawahara, Yuichi Hirose, Tatusya Takayama, Yoichi Nakazato, Yoshitaka Narita, Tatsuhiro Shibata, Masao Matsutani, Toshikazu Ushijima, Ryo Nishikawa, Koichi Ichimura, . Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathol.. 2017.03; 133 (3): 445-462. ( PubMed, DOI )

28. Taishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, Jun Nakabayashi, Kazuhiro Tanaka, Kaoru Tamura, Kensuke Tateishi, Manabu Kinoshita, Shintaro Fukushima, Hirokazu Takami, Kohei Fukuoka, Kai Yamazaki, Yuko Matsushita, Makoto Ohno, Yasuji Miyakita, Soichiro Shibui, Atsuhiko Kubo, Takashi Shuto, Sylvia Kocialkowski, Shoji Yamanaka, Akitake Mukasa, Takashi Sasayama, Kazuhiko Mishima, Taketoshi Maehara, Nobutaka Kawahara, Motoo Nagane, Yoshitaka Narita, Hiroyuki Mano, Toshikazu Ushijima, Koichi Ichimura. Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma. Acta Neuropathol.. 2017.02; 133 (2): 321-324. ( PubMed, DOI )

29. Takahiro Ogishima, Kaoru Tamura, Daisuke Kobayashi, Motoki Inaji, Shihori Hayashi, Reina Tamura, Tadashi Nariai, Kenji Ishii, Taketoshi Maehara. ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations. Brain Tumor Pathol. 2017.01; 34 (1): 20-27. ( PubMed, DOI )

30. Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Asanao Shimokawa, Hirokazu Takami, Shota Tanaka, Akitake Mukasa, Mitsuaki Shirahata, Saki Shimizu, Kaori Suzuki, Kuniaki Saito, Keiichi Kobayashi, Fumi Higuchi, Takeo Uzuka, Ryohei Otani, Kaoru Tamura, Kazutaka Sumita, Makoto Ohno, Yasuji Miyakita, Naoki Kagawa, Naoya Hashimoto, Ryusuke Hatae, Koji Yoshimoto, Naoki Shinojima, Hideo Nakamura, Yonehiro Kanemura, Yoshiko Okita, Manabu Kinoshita, Kenichi Ishibashi, Tomoko Shofuda, Yoshinori Kodama, Kanji Mori, Yusuke Tomogane, Junya Fukai, Koji Fujita, Yuzo Terakawa, Naohiro Tsuyuguchi, Shusuke Moriuchi, Masahiro Nonaka, Hiroyoshi Suzuki, Makoto Shibuya, Taketoshi Maehara, Nobuhito Saito, Motoo Nagane, Nobutaka Kawahara, Keisuke Ueki, Toshiki Yoshimine, Etsuo Miyaoka, Ryo Nishikawa, Takashi Komori, Yoshitaka Narita, Koichi Ichimura. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun. 2016.08; 4 (1): 79. ( PubMed, DOI )

31. Koichi Ichimura, Shintaro Fukushima, Yasushi Totoki, Yuko Matsushita, Ayaka Otsuka, Arata Tomiyama, Tohru Niwa, Hirokazu Takami, Taishi Nakamura, Tomonari Suzuki, Kohei Fukuoka, Takaaki Yanagisawa, Kazuhiko Mishima, Yoichi Nakazato, Fumie Hosoda, Yoshitaka Narita, Soichiro Shibui, Akihiko Yoshida, Akitake Mukasa, Nobuhito Saito, Toshihiro Kumabe, Masayuki Kanamori, Teiji Tominaga, Keiichi Kobayashi, Saki Shimizu, Motoo Nagane, Toshihiko Iuchi, Masahiro Mizoguchi, Koji Yoshimoto, Kaoru Tamura, Taketoshi Maehara, Kazuhiko Sugiyama, Mitsutoshi Nakada, Keiichi Sakai, Yonehiro Kanemura, Masahiro Nonaka, Akio Asai, Kiyotaka Yokogami, Hideo Takeshima, Nobutaka Kawahara, Tatsuya Takayama, Masahiro Yao, Mamoru Kato, Hiromi Nakamura, Natsuko Hama, Ryuichi Sakai, Toshikazu Ushijima, Masao Matsutani, Tatsuhiro Shibata, Ryo Nishikawa, . Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Acta Neuropathol.. 2016.06; 131 (6): 889-901. ( PubMed, DOI )

32. T Nakamura, K Tateishi, T Niwa, Y Matsushita, K Tamura, M Kinoshita, K Tanaka, S Fukushima, H Takami, H Arita, A Kubo, T Shuto, M Ohno, Y Miyakita, S Kocialkowski, T Sasayama, N Hashimoto, T Maehara, S Shibui, T Ushijima, N Kawahara, Y Narita, K Ichimura. Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. Neuropathol. Appl. Neurobiol.. 2016.04; 42 (3): 279-290. ( PubMed, DOI )

33. Hirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, Tomonari Suzuki, Takaaki Yanagisawa, Yuko Matsushita, Taishi Nakamura, Hideyuki Arita, Akitake Mukasa, Nobuhito Saito, Masayuki Kanamori, Toshihiro Kumabe, Teiji Tominaga, Keiichi Kobayashi, Motoo Nagane, Toshihiko Iuchi, Kaoru Tamura, Taketoshi Maehara, Kazuhiko Sugiyama, Mitsutoshi Nakada, Yonehiro Kanemura, Masahiro Nonaka, Kiyotaka Yokogami, Hideo Takeshima, Yoshitaka Narita, Soichiro Shibui, Yoichi Nakazato, Ryo Nishikawa, Koichi Ichimura, Masao Matsutani. Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors. J. Neurooncol.. 2015.08; 124 (1): 23-32. ( PubMed, DOI )

34. Sung Hugh Choi, Kaoru Tamura, Rajiv Kumar Khajuria, Deepak Bhere, Irina Nesterenko, Jack Lawler, Khalid Shah. Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas. Mol. Ther.. 2015.02; 23 (2): 235-243. ( PubMed, DOI )

35. Matthias Duebgen, Jordi Martinez-Quintanilla, Kaoru Tamura, Shawn Hingtgen, Navid Redjal, Hiroaki Wakimoto, Khalid Shah. Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. J. Natl. Cancer Inst.. 2014.06; 106 (6): dju090. ( PubMed, DOI )

36. Kaoru Tamura, Masaru Aoyagi. Stem cells and the origin of different glioma subtypes. Response. J. Neurosurg.. 2014.04; 120 (4): 1010-1011. ( PubMed )

37. Kaoru Tamura, Masaru Aoyagi. CD133-positive stem cells. Response. J. Neurosurg.. 2014.04; 120 (4): 1012. ( PubMed )

38. Kaoru Tamura, Masaru Aoyagi, Noboru Ando, Takahiro Ogishima, Hiroaki Wakimoto, Masaaki Yamamoto, Kikuo Ohno. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. J. Neurosurg.. 2013.11; 119 (5): 1145-1155. ( PubMed, DOI )

39. Masaru Aoyagi, Yoshihisa Kawano, Masashi Tamaki, Kaoru Tamura, Kikuo Ohno. Combined extradural subtemporal and anterior transpetrosal approach to tumors located in the interpeduncular fossa and the upper clivus. Acta Neurochir (Wien). 2013.08; 155 (8): 1401-1407. ( PubMed, DOI )

40. Kaoru Tamura, Hiroaki Wakimoto, Aayush S Agarwal, Samuel D Rabkin, Deepak Bhere, Robert L Martuza, Toshihiko Kuroda, Randa Kasmieh, Khalid Shah. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors. Mol. Ther.. 2013.01; 21 (1): 68-77. ( PubMed, DOI )